(Press-News.org) Women in the UK, and elsewhere, are still missing out on vital treatment for their No 1 killer—cardiovascular disease—despite significant progress in the medical management of heart disease and stroke, concludes a consensus statement published online in the journal Heart.
They continue to be underdiagnosed, undertreated, and underrepresented in clinical trials in all areas of cardiovascular disease, says the statement. Among other things, it calls for dedicated women’s heart champions and heart hubs, plus a women’s health strategy, to stop the needless death toll from what is essentially, preventable disease.
The consensus statement was drawn up by representatives from UK cardiovascular, nursing, and patient bodies affiliated with the British Cardiovascular Society, with the aim of addressing unmet needs, ensuring parity of care, and improving the health outcomes of women with cardiovascular disease in the UK, and worldwide.
Conventional cardiovascular disease risk factors, such as high blood pressure and high cholesterol, are often not treated as promptly or as appropriately as they are in men, despite accounting for around half of all preventable cardiovascular disease deaths, says the statement.
And women face particular cultural, societal, and financial issues, which magnify their heart disease risks, as well as enduring the influence of hormones, pregnancy, and the menopause, across their lifespan, notes the Statement.
And their biology, physiology, and body shape not only affect their risks of cardiovascular disease, but also the effectiveness of diagnostic procedures and treatment, it adds.
Healthcare professionals and the public mistakenly believe that women’s risk of cardiovascular disease is lower than men’s, says the statement. “Myths and unconscious biases within clinical practices and societal perceptions further obscure the reality that heart disease does not discriminate by sex,” it says.
And all too often women’s voices are unheard and their heart symptoms aren’t taken seriously enough, it adds.
The statement sets out a series of actions for clinicians and their professional bodies in each of the major cardiovascular disease areas of: coronary artery disease; valvular disease; heart failure; inherited heart disease; congenital heart defects; and heart rhythm disorders.
These include:
Raising awareness of traditional and women-specific risk factors for all types of cardiovascular disease
Ensuring that women are included in cardiovascular disease research
Making sure that the public and clinicians know that coronary artery disease is the leading cause of death for women
Ensuring equitable access to specialist cardiac care, genetic testing, and family screening for women with inherited heart disease
Addressing the under-representation of women in clinical trials of new cancer immunotherapy treatments
Setting up registries to monitor cardiac toxicity as a result of cancer chemotherapy for everyone, and specifically for women
Enhancing women’s participation in cardiac rehabilitation programmes by offering flexible hybrid/virtual options
Increasing clinician awareness of the strengths and limitations of each diagnostic method in women with confirmed or suspected cardiovascular disease
Making women’s cardiovascular disease health ‘everyone’s responsibility’ by including this in primary care clinicians’ contractual obligations
Leveraging influence to highlight and address sex biases in healthcare
Patients and those advocating on their behalf also have a role in advancing women’s cardiovascular disease care, says the statement.
For example, they should:
Call for a holistic woman-centred approach to heart care that incorporates women’s experiences and insights
They should engage the media, among others, to raise awareness about the importance of cardiovascular health for women.
Tailor information to the unique needs of women
Highlight heart conditions that predominantly or exclusively affect women
Co-design training for healthcare professionals to become more attuned to women’s specific needs
The statement also calls for the establishment of women’s heart champions to offer peer to peer support and dedicated women’s heart hubs to check on conventional risk factors, such as blood pressure, cholesterol, and weight, and provide lifestyle advice on diet and exercise. And a dedicated women’s health strategy should be created, it suggests.
Health professionals, professional bodies, charities, and the NHS can do their bit by mounting coordinated campaigns with unified messaging to raise the profile of women’s heart health, it says.
“Despite significant progress in the management of [cardiovascular disease], it remains the UK’s number one killer for women. Unfortunately, women are underdiagnosed, undertreated, and under-represented in all [cardiovascular disease] areas,” says the statement.
If its recommendations are followed, these will “address the sex disparities in everyday care of patients in all settings, aiming at saving many women from losing their lives unnecessarily from preventable conditions in the UK and also worldwide,” it concludes.
Professor André Ng, President of the British Cardiovascular Society, which co-owns Heart with BMJ Group commented: "The joint British Cardiovascular Societies' consensus document is the first to comprehensively detail the many layers of inequalities that exist in relation to cardiovascular disease in women, who clearly need better access to early and accurate diagnosis and timely treatment. Raising awareness across the medical profession, to patients and the general public is an important first step.
“The British Cardiovascular Society will work with our affiliated societies in all areas of cardiology as well as other stakeholders, including patient organisations and NHS leaders, to identify key work packages that will bring transformative change to improve care and achieve better outcomes for cardiovascular care in female patients."
END
Women still missing out on treatment for their No 1 killer—cardiovascular disease
Despite major progress in disease management, they are underdiagnosed and undertreated. Dedicated heart champions, hubs, and health strategy among key actions needed
2024-09-24
ELSE PRESS RELEASES FROM THIS DATE:
Palestinian education ‘under attack’, leaving a generation close to losing hope, study warns
2024-09-24
The ongoing war in Gaza will set children and young people’s education back by up to five years and risks creating a lost generation of permanently traumatised Palestinian youth, a new study warns.
The report, by a team of academics working in partnership with the United Nations Relief and Works Agency for Palestinian Refugees in the Near East (UNRWA), is the first to comprehensively quantify the war’s toll on learning since it began in October 2023. It also details the devastating impact on children, young people and teachers, supported by new accounts from frontline staff and ...
Semaglutide improves outcomes for obese patients with common skin condition, new study shows
2024-09-24
(Wednesday, 25 September 2024, Amsterdam, Netherlands) A pioneering study, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.1
This is the first study to explore the use of semaglutide for HS, marking a critical milestone in the search for effective treatments for this painful and debilitating condition.
HS is currently estimated to affect approximately 1 in 100 people, with obesity being a significant risk factor. The condition is characterised ...
Could GLP1RA drugs lower high iron levels?
2024-09-24
GLP1RA agonists have been increasing in popularity for treating obesity and type 2 diabetes.
With this novel treatment proving to be very effective, researchers are curious to know more about what other potential treatments it could also hold.
Researchers at the University of Michigan investigated another potential way GLP1RA drugs can be useful in treating type two diabetes associated with a genetic condition that causes high levels of iron, called hereditary hemochromatosis.
High iron levels with hereditary hemochromatosis can cause predisposition to liver disease ...
C-Path’s PKD outcomes consortium receives BAA Award for project to advance drug development tools for autosomal dominant tubulointerstitial kidney disease
2024-09-24
TUCSON, Ariz., Sept. 19, 2024 — Critical Path Institute (C-Path) is thrilled to announce its Polycystic Kidney Disease Outcomes Consortium (PKDOC) has been awarded an Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) focused Broad Agency Announcement (BAA) contract from the U.S. Food and Drug Administration (FDA). The overarching objective of the work supported by the BAA award is to leverage collaboration with the Wake Forest Rare Inherited Kidney Disease team and its ADTKD registry, to analyze clinical and laboratory data that will help evaluate prognosis in ADTKD and help set the stage for future clinical trials.
ADTKD only affects ...
New insights into hot carrier solar cells: Increasing generation and extraction
2024-09-24
Hot carrier solar cells, a concept introduced several decades ago, have long been seen as a potential breakthrough in solar energy technology. These cells could surpass the Shockley–Queisser efficiency limit, which is a theoretical maximum efficiency for single-junction solar cells. Despite their promise, practical implementation has faced significant challenges, particularly in managing the rapid extraction of hot electrons across material interfaces.
Recent research has focused on using satellite valleys in the conduction band to temporarily store hot electrons before collection. However, ...
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes
2024-09-24
(MEMPHIS, Tenn. – Sept. 24, 2024) – Clinical trial results from St. Jude Children’s Research Hospital demonstrate benefits to using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL). Traditionally, the intensity of a patient’s chemotherapy regime is guided by the National Cancer Institute (NCI) risk classification, which is largely determined by clinical characteristics such as age and white blood cell count at presentation. Through the flagship St. Jude ...
How emotion boosts memory for context
2024-09-24
Researchers at the Beckman Institute for Advanced Science and Technology demonstrated that emotion enhances memory for contextual details, challenging the view that emotion impairs the ability to remember such information.
The report was led by doctoral student Paul Bogdan, currently a postdoc at Duke University, and Florin and Sanda Dolcos, professors of psychology and neuroscience at the University of Illinois Urbana-Champaign.
Their research appears in the Journal of Experimental Psychology: ...
Specially designed video games may benefit mental health of children and teenagers
2024-09-24
In a review of previous studies, a Johns Hopkins Children’s Center team concludes that some video games created as mental health interventions can be helpful – if modest – tools in improving the mental well-being of children and teens with anxiety, depression and attention-deficit/hyperactivity disorder (ADHD).
A report on the review of studies from peer-reviewed journals between 2011 and March 20, 2024, was published Sept. 23, 2024, in JAMA Pediatrics.
An estimated 20% of children and teenagers between the ages of three and 17 in the U.S. have a mental, emotional, developmental or behavioral ...
President Obama 2012 reelection linked to significantly better mental health in Black men — but only those with a college education
2024-09-24
Following Barack Obama’s reelection as U.S. president in 2012, the mental health of college-educated Black men improved significantly, while those who didn’t attend college reported worse mental health, according to new research from Rice University sociologists.
“Four More Years! Or So What? The Mental Health Significance of Barack Obama’s 2012 Presidential Re-Election among Black Adults” will appear in an upcoming edition of Du Bois Review: Social Science Research on Race.
Lead researcher Tony Brown, distinguished professor of sociology at Rice, said he and his co-authors were interested in following up ...
Finding the sweet spot: Machine learning reveals factors for successful crowdfunding
2024-09-24
Toronto -- Modern crowdfunding has grown from relatively modest beginnings in the late 1990s to a multi-billion-dollar financing market for all kinds of early-stage innovations. The platform Kickstarter alone went from $276 million pledged in 2012 to $7.8 billion in 2024. There are even professional project designers to help craft that winning proposal.
With stakes like those, getting the pitch right is everything.
Enter machine learning to assist. Researchers from the University of Toronto’s Rotman School of Management put four different types of this artificial intelligence application to the test, including Deep Learning. Machine learning proved not only superior ...
LAST 30 PRESS RELEASES:
Osteoporosis treatment benefits people older than 80
Consuming more protein may protect patients taking anti-obesity drug from muscle loss
Thyroid treatment may improve gut health in people with hypothyroidism
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss
High blood sugar may have a negative impact on men’s sexual health
Emotional health of parents tied to well-being of children with growth hormone deficiency
Oxytocin may reduce mood changes in women with disrupted sleep
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury
Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1
Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce
Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes
New research expands laser technology
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers
Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes
CTE and normal aging are difficult to distinguish, new study finds
Molecular arms race: How the genome defends itself against internal enemies
Tiny chip speeds up antibody mapping for faster vaccine design
KTU experts reveal why cultural heritage is important for community unity
More misfolded proteins than previously known may contribute to Alzheimer’s and dementia
“Too much going on”: Autistic adults overwhelmed by non-verbal social cues
What’s driving America’s deep freezes in a warming world?
A key role of brain protein in learning and memory is deciphered by scientists
Heart attacks don’t follow a Hollywood script
Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories
Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds
Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%
Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR
New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications
[Press-News.org] Women still missing out on treatment for their No 1 killer—cardiovascular diseaseDespite major progress in disease management, they are underdiagnosed and undertreated. Dedicated heart champions, hubs, and health strategy among key actions needed